Skip to main content

Advertisement

Table 2 Use of antidepressants, antipsychotics, benzodiazepines and mood stabilizers during the study period

From: Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial

  Lithium + Usual care (n = 29) Usual care (n = 25) p
  N % n %  
Antidepressants 26 96 23 100 1.000
Antipsychotics 16 59 16 70 0.449
Benzodiazepines 23 85 20 87 0.100
Mood stabilizers 10 37 10 43 0.643